Giles F - Search Results

1

Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.

Giles F, Verstovsek S, Thomas D, Gerson S, Cortes J, Faderl S, Ferrajoli A, Ravandi F, Kornblau S, Garcia-Manero G, Jabbour E, O'Brien S, Karsten V, Cahill A, Yee K, Albitar M, Sznol M, Kantarjian H. Giles F, et al. Clin Cancer Res. 2005 Nov 1;11(21):7817-24. doi: 10.1158/1078-0432.CCR-05-1070. Clin Cancer Res. 2005. PMID: 16278404 Clinical Trial.

2

Biology and treatment of chronic myelogenous leukemia.

Giles FJ, Kantarjian HM. Giles FJ, et al. Oncology (Williston Park). 1997 Sep;11(9):1295-300; discussion 1302-10. Oncology (Williston Park). 1997. PMID: 9306419

3

Chronic lymphocytic leukemia in (Richter's) transformation.

Giles FJ, O'Brien SM, Keating MJ. Giles FJ, et al. Semin Oncol. 1998 Feb;25(1):117-25. Semin Oncol. 1998. PMID: 9482533 Review.

4

Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.

Kantarjian HM, Giles FJ, O'Brien SM, Talpaz M. Kantarjian HM, et al. Among authors: giles fj. Hematol Oncol Clin North Am. 1998 Feb;12(1):31-80. doi: 10.1016/s0889-8588(05)70496-2. Hematol Oncol Clin North Am. 1998. PMID: 9523225 Review.

5

Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Beran M, Estey E, O'Brien SM, Giles FJ, Koller CA, Kornblau S, Keating M, Kantarjian HM. Beran M, et al. Among authors: giles fj. Leuk Lymphoma. 1998 Nov;31(5-6):521-31. doi: 10.3109/10428199809057611. Leuk Lymphoma. 1998. PMID: 9922042 Clinical Trial.

6

Granulocytic sarcoma of the pancreas: a report of two cases and literature review.

Ravandi-Kashani F, Estey E, Cortes J, Medeiros LJ, Giles FJ. Ravandi-Kashani F, et al. Among authors: giles fj. Clin Lab Haematol. 1999 Jun;21(3):219-24. doi: 10.1046/j.1365-2257.1999.00205.x. Clin Lab Haematol. 1999. PMID: 10448606

7

Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.

Kantarjian HM, O'Brien S, Smith TL, Rios MB, Cortes J, Beran M, Koller C, Giles FJ, Andreeff M, Kornblau S, Giralt S, Keating MJ, Talpaz M. Kantarjian HM, et al. Among authors: giles fj. J Clin Oncol. 1999 Jan;17(1):284-92. doi: 10.1200/JCO.1999.17.1.284. J Clin Oncol. 1999. PMID: 10458244 Clinical Trial.

8

Multidrug resistance protein expression in chronic myeloid leukemia: associations and significance.

Giles FJ, Kantarjian HM, Cortes J, Thomas DA, Talpaz M, Manshouri T, Albitar M. Giles FJ, et al. Cancer. 1999 Sep 1;86(5):805-13. Cancer. 1999. PMID: 10463979

9

Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.

Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M. Estey EH, et al. Among authors: giles fj. Blood. 1999 Oct 1;94(7):2230-5. Blood. 1999. PMID: 10498593 Free article. Clinical Trial.

10

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.

Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S, Giles FJ, Gajewski J, Pierce S, Keating MJ. Thomas DA, et al. Among authors: giles fj. Cancer. 1999 Oct 1;86(7):1216-30. doi: 10.1002/(sici)1097-0142(19991001)86:7<1216::aid-cncr17>3.0.co;2-o. Cancer. 1999. PMID: 10506707 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

715 results

Search Page

Filters